Pediatric Surgery International

, Volume 29, Issue 3, pp 275–279 | Cite as

Primary hyperparathyroidism in adolescents: the same but different

  • Itai Pashtan
  • Raymon H. Grogan
  • Sharone P. Kaplan
  • Karen Devon
  • Peter Angelos
  • Donald Liu
  • Edwin L. Kaplan
Original Article



Primary hyperparathyroidism has been studied more extensively in adults than in adolescents. The objective of this study is to define the similarities and differences that exist between these groups.


A retrospective review of 1,000 primary hyperparathyroidism patients undergoing parathyroidectomy at a single tertiary-care university teaching hospital between 1990 and 2004. All patients 20 years of age or younger comprised our study cohort, and were compared to two historical adult groups.


Of 1,000 parathyroidectomies, 21 (2.1 %) were 20 years of age or younger (adolescent). The adolescents presented with higher serum calcium levels (p < 0.01) more severe symptoms (p = 0.02), more renal stones (p = 0.048), and a higher incidence of hypercalcemic crisis (p = 0.02), when compared with adults. We found that 67 % suffered from a triad of tiredness, weakness, and depression versus 39 % of adults (p = 0.02). Sestamibi scans were less helpful in the adolescents than in adults. Similar to the adults, 86 % of adolescent patients had single gland disease, and 95 % were cured at the first operation.


Adolescents with primary hyperparathyroidism typically have more severe disease than adults. Contrary to popular belief, most adolescents have single gland disease and not hyperplasia associated with a genetic disorder.


Adolescent hyperparathyroidism Pediatric hyperparathyroidism Parathyroidectomy Hypercalcemic crisis 


Conflict of interest



  1. 1.
    Salti GI, Fedorak I, Yashiro T, Fulton N, Hara H, Yousefzadeh D, Kaplan EL (1992) Continuing evolution in the operative management of primary hyperparathyroidism. Arch Surg 127:831–836 (discussion 836–837)PubMedCrossRefGoogle Scholar
  2. 2.
    Miller BS, Dimick J, Wainess R, Burney RE (2008) Age- and sex-related incidence of surgically treated primary hyperparathyroidism. World J Surg 32:795–799PubMedCrossRefGoogle Scholar
  3. 3.
    Loh KC, Duh QY, Shoback D, Gee L, Siperstein A, Clark OH (1998) Clinical profile of primary hyperparathyroidism in adolescents and young adults. Clin Endocrinol (Oxf) 48:435–443CrossRefGoogle Scholar
  4. 4.
    Harman CR, van Heerden JA, Farley DR, Grant CS, Thompson GB, Curlee K (1999) Sporadic primary hyperparathyroidism in young patients: a separate disease entity? Arch Surg 134:651–655 (discussion 655–656)PubMedCrossRefGoogle Scholar
  5. 5.
    Hsu SC, Levine MA (2002) Primary hyperparathyroidism in children and adolescents: the Johns Hopkins Children’s Center experience 1984–2001. J Bone Miner Res 17(Suppl 2):N44–N50PubMedGoogle Scholar
  6. 6.
    Joshua B, Feinmesser R, Ulanovski D, Gilat H, Sulkes J, Eshed V, Shpitzer T (2004) Primary hyperparathyroidism in young adults. Otolaryngol Head Neck Surg 131:628–632PubMedCrossRefGoogle Scholar
  7. 7.
    Sneider MS, Solorzano CC, Montano RE, Anello C, Irvin GL, Lew JI (2009) Sporadic primary hyperparathyroidism in young individuals: different disease and treatment? J Surg Res 155:100–103PubMedCrossRefGoogle Scholar
  8. 8.
    Jaskowiak NT, Sugg SL, Helke J, Koka MR, Kaplan EL (2002) Pitfalls of intraoperative quick parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism. Arch Surg 137:659–668 (discussion 668–669)PubMedCrossRefGoogle Scholar
  9. 9.
    Aparicio López C, Anton-Martin P, Gil-Fournier B, Ramiro-León S, Pérez-Nanclares G, Pérez de Nanclares G, Martínez Menéndez B, Castaño L (2012) Familial hypocalciuric hypercalcemia: new mutation in the CASR gene converting valine 697 to methionine. Eur J Pediatr 171:147–150PubMedCrossRefGoogle Scholar
  10. 10.
    Krubsack AJ, Wilson SD, Lawson TL, Kneeland JB, Thorsen MK, Collier BD, Hellman RS, Isitman AT (1989) Prospective comparison of radionuclide, computed tomographic, sonographic, and magnetic resonance localization of parathyroid tumors. Surgery 106:639–644 (discussion 644–646)PubMedGoogle Scholar
  11. 11.
    Melloul M, Paz A, Koren R, Cytron S, Feinmesser R, Gal R (2001) 99mTc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance. Eur J Nucl Med 28:209–213PubMedCrossRefGoogle Scholar
  12. 12.
    Saxe AW, Gibson GW, Russo IH, Gimotty P (1992) Measurement of estrogen and progesterone receptors in abnormal human parathyroid tissue. Calcif Tissue Int 51:344–347PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Itai Pashtan
    • 1
  • Raymon H. Grogan
    • 1
  • Sharone P. Kaplan
    • 1
  • Karen Devon
    • 1
  • Peter Angelos
    • 1
  • Donald Liu
    • 2
  • Edwin L. Kaplan
    • 1
  1. 1.Endocrine Surgery Research Program, Department of SurgeryUniversity of Chicago Pritzker School of MedicineChicagoUSA
  2. 2.Section of Pediatric Surgery, Department of SurgeryUniversity of Chicago Pritzker School of MedicineChicagoUSA

Personalised recommendations